Langues

23 November 2017 - Neurolixis showcased online by "LaBiotech"

Neurolixis was recently showcased as the 'Biotech Of The Week" by LaBiotech.eu, the online European biotech networking website. The LaBiotech.eu article drew attention to Neurolixis' CNS drug development programs: NLX-112 for treatment of dyskinesia in Parkinson's disease, a disorder principally found in elderly patients; and NLX-101 for treatment of respiratory dysfunction in Rett syndrome, a rare orphan disorder that manifests itself in young girls.

Read the LaBiotech.eu article here.